FDA Inspection 1336606 — Shanghai STA Pharmaceutical Product Co., Ltd.
The FDA completed an inspection of Shanghai STA Pharmaceutical Product Co., Ltd. on Feb 28, 2025 in Shanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)
Additional Details
Mutual Recognition Agreement (MRA)